Part,  Chapter, Paragraph

 1   II,     5.  2.  7|            J Public Health 95 (1): 103-108.~WHO Expert Committee (
 2   II,     5.  4.  8|         Metabolism 2001;14(2), 100-103.~Carinci M, Federici Orsini
 3   II,     5.  5.  3|            in Cyprus. J Neurol Sci 103:29-36.~Milanov I, Georgiev
 4   II,     5.  5.  3|            risk. Acta Neurol Scand 103:20-26~Pugliatti M, Sotgiu
 5   II,     5.  5.  3|         Finland. Acta Neurol Scand 103:153-158.~Sumelahti ML, Tienari
 6   II,     5.  5.  3|          Sweden. Acta Neurol Scand 103:214-218.~Sundström P, Nyström
 7   II,     5.  6.  6|          quality of life. Am J Med 103:12S-17S~Cooper C, Atkinson
 8   II,     5. 12.  7|       Naples, Italy. Public Health 103:385-389.~de la Pena J, Brullet
 9   II,     6.  3.  6|            years. In 2005, some 15 103 cases were reported by 18
10   II,     9.  1.  1|           Gynecol Reprod Biol 2002;103(1):4-13.~Apgar V (1953): A t.
11   II,     9.  1.  1| meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kramer MS,
12   II,     9.  1.  1|  implications. Obstet Gynecol 2004;103(1):128-36.~Luke B, Brown
13   II,     9.  1.  1|    artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin J, Wildman K,
14   II,     9.  3.  1|       Social Science & Medicine 62 103115~ ~Association of European
15   II,     9.  3.  2|           Gynecol Reprod Biol 2002;103(1):4-13.~ ~Ananth CV, Joseph
16   II,     9.  3.  2| meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kahn B, Lumey
17   II,     9.  3.  2|  implications. Obstet Gynecol 2004;103(1):128-36.~ ~London: Stationery
18   II,     9.  3.  2|    artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin J, Wildman K,
19   II,     9.  4.  7|           Age and Ageing. vol. 35, 103-105.~ ~Rathmann W, Haastert
20  III,    10.  2.  1|           Public Health Vol. 14(2):103-109.~ ~Greyling T et al. (
21   IV,    11.  6.  5|       index." Health Economics 11: 103-115.~ ~Wagstaff A, van Doorslaer
22   IV,    12. 10    |  Ministerial Decision 37411/1829/E 103 defining the relevant bodies,